China Cord Blood Corp Company Profile (NYSE:CO)

About China Cord Blood Corp (NYSE:CO)

China Cord Blood Corp logoChina Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants. As of March 31, 2016, the Company had three operating cord blood banks.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Symbol: NYSE:CO
  • CUSIP: N/A
  • Web: www.chinacordbloodcorp.com
Capitalization:
  • Market Cap: $663.6 million
  • Outstanding Shares: 73,003,000
Average Prices:
  • 50 Day Moving Avg: $7.47
  • 200 Day Moving Avg: $6.08
  • 52 Week Range: $4.27 - $9.15
P/E:
  • Trailing P/E Ratio: 47.59
  • Foreward P/E Ratio: 53.47
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $103.7 million
  • Price / Sales: 6.40
  • Book Value: $3.51 per share
  • Price / Book: 2.59
Profitability:
  • EBIDTA: $43.24 million
  • Net Margins: 13.38%
  • Return on Equity: 5.30%
  • Return on Assets: 1.93%
Debt:
  • Debt-to-Equity Ratio: 0.24%
  • Current Ratio: 3.49%
  • Quick Ratio: 3.46%
Misc:
  • Average Volume: 217,102 shs.
  • Beta: 0.95
  • Short Ratio: 2.25
 

Frequently Asked Questions for China Cord Blood Corp (NYSE:CO)

What is China Cord Blood Corp's stock symbol?

China Cord Blood Corp trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."

How were China Cord Blood Corp's earnings last quarter?

China Cord Blood Corp (NYSE:CO) released its quarterly earnings data on Monday, August, 22nd. The company reported $0.03 EPS for the quarter, meeting the consensus estimate of $0.03. The business earned $26 million during the quarter, compared to the consensus estimate of $26.23 million. China Cord Blood Corp had a net margin of 13.38% and a return on equity of 5.30%. View China Cord Blood Corp's Earnings History.

When will China Cord Blood Corp make its next earnings announcement?

China Cord Blood Corp is scheduled to release their next quarterly earnings announcement on Monday, June, 12th 2017. View Earnings Estimates for China Cord Blood Corp.

Who are some of China Cord Blood Corp's key competitors?

Who owns China Cord Blood Corp stock?

China Cord Blood Corp's stock is owned by a number of of retail and institutional investors. Top institutional investors include GOLDEN MEDITECH HOLDINGS LTD (65.40%), GOLDEN MEDITECH HOLDINGS LTD (65.40%), Credit Suisse AG (1.56%), Renaissance Technologies LLC (1.18%), Acadian Asset Management LLC (0.81%) and PEAK6 Investments L.P. (0.30%). View Institutional Ownership Trends for China Cord Blood Corp.

Who sold China Cord Blood Corp stock? Who is selling China Cord Blood Corp stock?

China Cord Blood Corp's stock was sold by a variety of institutional investors in the last quarter, including Credit Suisse AG, Bank of America Corp DE, PEAK6 Investments L.P., California Public Employees Retirement System and Parametric Portfolio Associates LLC. View Insider Buying and Selling for China Cord Blood Corp.

Who bought China Cord Blood Corp stock? Who is buying China Cord Blood Corp stock?

China Cord Blood Corp's stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Brandes Investment Partners LP, Spark Investment Management LLC, Acadian Asset Management LLC, Financial Counselors Inc. and Commonwealth of Pennsylvania Public School Empls Retrmt SYS. View Insider Buying and Selling for China Cord Blood Corp.

How do I buy China Cord Blood Corp stock?

Shares of China Cord Blood Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of China Cord Blood Corp stock cost?

One share of China Cord Blood Corp stock can currently be purchased for approximately $9.09.

Analyst Ratings

Consensus Ratings for China Cord Blood Corp (NYSE:CO) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for China Cord Blood Corp (NYSE:CO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
2/6/2016ScotiabankReiterated RatingSector PerformN/AView Rating Details
2/5/2016Howard WeilDowngradeOutperform -> Sector PerformN/AView Rating Details
11/25/2015Roth CapitalReiterated RatingHoldN/AView Rating Details
10/6/2015Credit Suisse Group AGReiterated RatingOutperformN/AView Rating Details
8/10/2015Jefferies Group LLCReiterated RatingBuy$11.00N/AView Rating Details
(Data available from 5/26/2015 forward)

Earnings

Earnings History for China Cord Blood Corp (NYSE:CO)
Earnings by Quarter for China Cord Blood Corp (NYSE:CO)
Earnings History by Quarter for China Cord Blood Corp (NYSE:CO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
6/12/2017        
2/24/2017Q317$0.04$0.10$28.93 millionViewListenView Earnings Details
11/17/2016Q217$0.04$0.03$27.37 million$27.61 millionViewListenView Earnings Details
8/22/2016Q117$0.03$0.03$26.23 million$26.00 millionViewN/AView Earnings Details
6/14/2016Q416$0.03$0.03$25.87 million$24.31 millionViewListenView Earnings Details
11/23/2015Q216$0.04$0.05$26.42 million$27.00 millionViewListenView Earnings Details
8/19/2015Q116$0.04$0.03$25.81 million$26.70 millionViewListenView Earnings Details
6/18/2015Q415$0.05$0.04$25.88 million$26.30 millionViewListenView Earnings Details
2/25/2015Q315$0.06$0.07$26.35 million$26.90 millionViewListenView Earnings Details
11/25/2014Q2$0.06$0.06$25.30 million$24.78 millionViewListenView Earnings Details
8/28/2014Q1$0.06$0.06$24.78 million$24.72 millionViewListenView Earnings Details
6/18/2014Q414$0.07$0.07$24.41 million$24.44 millionViewN/AView Earnings Details
2/24/2014Q3$0.06$0.07$24.22 million$24.90 millionViewListenView Earnings Details
1/31/2014Q4($0.25)ViewN/AView Earnings Details
11/15/2013Q2$0.06$0.06$22.32 million$23.10 millionViewListenView Earnings Details
8/26/2013Q1 2014$0.04$0.07$21.62 million$21.00 millionViewListenView Earnings Details
6/18/2013Q4 2013$0.02$0.05$16.59 million$21.40 millionViewListenView Earnings Details
11/19/2012Q312$0.05$18.53 million$20.40 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for China Cord Blood Corp (NYSE:CO)
2017 EPS Consensus Estimate: $0.16
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.03$0.03$0.03
Q2 20171$0.04$0.04$0.04
Q3 20171$0.04$0.04$0.04
Q4 20171$0.05$0.05$0.05
(Data provided by Zacks Investment Research)

Dividends

Dividend History for China Cord Blood Corp (NYSE:CO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for China Cord Blood Corp (NYSE:CO)
Institutional Ownership Percentage: 7.93%
Insider Trades by Quarter for China Cord Blood Corp (NYSE:CO)
Institutional Ownership by Quarter for China Cord Blood Corp (NYSE:CO)
Insider Trades by Quarter for China Cord Blood Corp (NYSE:CO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/21/2015Kent C MccarthyInsiderBuy20,000$4.60$92,000.00View SEC Filing  
1/16/2015Kent C MccarthyInsiderBuy50,000$4.30$215,000.00View SEC Filing  
1/14/2015Private Equity Fund Jayhawk IIInsiderBuy10,000$4.52$45,200.00View SEC Filing  
1/12/2015Private Equity Fund Jayhawk IIInsiderBuy50,000$4.69$234,500.00View SEC Filing  
11/28/2014Robert Douglas CudneyInsiderBuy200,000$0.01$1,000.00
11/17/2014Kent C MccarthyInsiderBuy26,754$4.70$125,743.80View SEC Filing  
11/6/2014Kent C MccarthyInsiderBuy150,000$5.16$774,000.00View SEC Filing  
9/29/2014Kent C MccarthyInsiderBuy10,000$5.00$50,000.00View SEC Filing  
9/10/2014Kent C MccarthyInsiderBuy9,900$4.98$49,302.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for China Cord Blood Corp (NYSE:CO)
Latest Headlines for China Cord Blood Corp (NYSE:CO)
Source:
DateHeadline
ft.com logoInvestment is in the blood for stem cell futurists
www.ft.com - May 25 at 5:57 PM
americanbankingnews.com logoChina Cord Blood Corp (CO) Given Daily Media Impact Rating of 0.10
www.americanbankingnews.com - May 2 at 3:18 PM
americanbankingnews.com logoSomewhat Positive News Coverage Extremely Likely to Impact China Cord Blood Corp (CO) Stock Price
www.americanbankingnews.com - April 28 at 4:39 PM
americanbankingnews.com logoChina Cord Blood Corp (CO) Getting Somewhat Positive News Coverage, Study Finds
www.americanbankingnews.com - April 25 at 4:55 PM
americanbankingnews.com logoChina Cord Blood Corp (CO) Earns Daily News Sentiment Score of -0.07
www.americanbankingnews.com - April 21 at 2:14 PM
americanbankingnews.com logoFavorable Press Coverage Somewhat Unlikely to Affect China Cord Blood Corp (CO) Share Price
www.americanbankingnews.com - April 18 at 3:49 PM
finance.yahoo.com logoChina Cord Blood Corp.: Strong price momentum but will it sustain?
finance.yahoo.com - April 14 at 4:45 PM
americanbankingnews.com logoChina Cord Blood Corp (CO) Given News Impact Rating of 0.04
www.americanbankingnews.com - April 13 at 12:22 PM
reuters.com logoBRIEF-China Cord Blood announces termination of evaluation and negotiation regarding "going private" proposal
www.reuters.com - April 13 at 10:04 AM
finance.yahoo.com logoChina Cord Blood Corporation Announces Termination of Evaluation and Negotiation Regarding "Going Private" Proposal
finance.yahoo.com - April 13 at 10:04 AM
americanbankingnews.com logoChina Cord Blood Corp (CO) Expected to Announce Quarterly Sales of $0.00
www.americanbankingnews.com - April 7 at 8:31 PM
reuters.com logoBRIEF-China Cord Blood Corp receives notification of exercise of 7% senior convertible notes
www.reuters.com - April 7 at 9:05 AM
finance.yahoo.com logoChina Cord Blood Corporation Receives Notification of Exercise of 7% Senior Convertible Notes
finance.yahoo.com - April 7 at 9:05 AM
reuters.com logoBRIEF-China Cord Blood Corp names Ting Zheng interim CEO of Beijing unit
www.reuters.com - March 31 at 4:33 PM
finance.yahoo.com logoChina Cord Blood Corporation Announces Executive Change
finance.yahoo.com - March 31 at 4:33 PM
seekingalpha.com logoChina Cord Blood (CO) Q3 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - February 27 at 3:58 PM
prnewswire.com logoChina Cord Blood Corporation Reports Financial Results for the Third Quarter ...
www.prnewswire.com - February 25 at 4:13 PM
rttnews.com logoEARNINGS SUMMARY: Details of China Cord Blood Corp Q3 Earnings Report
www.rttnews.com - February 24 at 9:50 PM
us.rd.yahoo.com logoChina Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017
us.rd.yahoo.com - February 24 at 9:50 PM
reuters.com logoBRIEF-China Cord Blood Corp reports qtrly earnings per share $0.10 - Reuters
www.reuters.com - February 24 at 4:47 PM
finance.yahoo.com logoChina Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017 - Yahoo Finance
finance.yahoo.com - February 24 at 4:47 PM
biz.yahoo.com logoQ3 2017 China Cord Blood Corp Earnings Release - After Market Close
biz.yahoo.com - February 24 at 12:19 PM
finance.yahoo.com logoDeportation plans cast shadow on Trump envoy talks with Mexico
finance.yahoo.com - February 23 at 4:22 PM
finance.yahoo.com logoUpset at Trump, Mexico voices 'worry and irritation' to U.S. envoys
finance.yahoo.com - February 23 at 4:22 PM
finance.yahoo.com logoChina Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2017 Financial Results
finance.yahoo.com - February 17 at 5:48 PM
uk.finance.yahoo.com logoEuropean shares slip as bank losses offset tech gains; FTSE hits new high
uk.finance.yahoo.com - February 9 at 4:49 PM
prnewswire.com logoSanpower Group Agrees to Acquire Dendreon From Valeant for $819.9 Million
www.prnewswire.com - January 10 at 10:12 PM
finance.yahoo.com logoSanpower Group Agrees to Acquire Dendreon From Valeant for $819.9 Million - Yahoo Finance
finance.yahoo.com - January 10 at 5:09 PM
uk.finance.yahoo.com logoEuropean shares slip, Britain's FTSE 100 at record high
us.rd.yahoo.com - January 9 at 5:33 PM
reuters.com logoBRIEF-China Cord Blood Corp receives notice of entry into conditional sale... - Reuters
www.reuters.com - January 5 at 6:18 AM
finance.yahoo.com logoChina Cord Blood Corporation Receives Notice of Entry Into Conditional Sale Agreement - Yahoo Finance
finance.yahoo.com - January 5 at 6:18 AM

Social

Chart

China Cord Blood Corp (CO) Chart for Friday, May, 26, 2017

This page was last updated on 5/26/2017 by MarketBeat.com Staff